The findings from part one showed clear benefits for patients on semaglutide compared to those receiving a placebo
You can access this policy by visiting our policy bulletin library at policy bulletin library
Hollis G, Huber R (2011) 11beta-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
CrossRef Cummings JL, Atri A, Sano M, et al
VP13 Estimating Meaningful Score Differences and Meaningful Score Regions for the PROMIS Pediatric Asthma Impact Scale Jing Yuan 1 , Li Lin 2 , Kevin Weinfurt 2 , Nicole Lucas 2 , Allison Burbank 3 , Michelle Hernandez 3 , I-Chan Huang 4 , Bryce Reeve 1 1 Duke University, Durham, North Carolina, USA, 2 Duke University School of Medicine, Durham, North Carolina, USA, 3 University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
Copyright 2026 KNOE